From: Anemia and red blood cell transfusion in critically ill cardiac patients
Health problem | Patients | Studies | Risk | |
---|---|---|---|---|
Outcome | (n) | (n) | (95% CI) | |
Meta-analyses | ||||
Mortalitya[14] | ACS | 51,449 | 10 | aOR: 1.49 (1.24 to 1.79) |
Mortalityb[9] | ACS | 171,915 | 27 | aHR: 1.49 (1.23 to 1.81) |
Studies not included in the meta-analyses | ||||
Mortality [15] | New heart failure | 12,065 | 1 | aHR: 1.34 (1.24 to 1.46) |
Mortality [16] | PCI | 6,116 | 1 | aHR: 1.8 (1.3 to 2.3) |
Mortality [17] | PCI | 48,851 | 1 | aOR: 2.29 (1.79 to 2.92) |
Mortality [18] | Cardiac surgery | 13,843 | 1 | 12.5% versus 7.5%, P = 0.014 |
Mortality [19] | CABG | 2,102 | 1 | aOR: 0.99 (0.98 to 1.0) |
Mortality [20] | ACS | 7,922 | 1 | aOR: 1.71 (1.34 to 2.17) |
Meta-analyses on other outcomes | ||||
Heart failurea[14] | ACS | 152,849 | 5 | OR: 1.96 (1.47 to 2.62) |
Cardiogenic shocka[14] | ACS | 129,136 | 4 | OR: 1.95 (1.04 to 2.64) |
Reinfarctionb[9] | ACS | 22,115 | 6 | RR: 1.25 (1.02 to 1.53) |